? ? Despite the availability of vaccines against influenza and pertussis, infants less than 6 months of age are not eligible to be vaccinated against influenza, are too young to be completely vaccinated against pertussis and therefore remain vulnerable to pertussis and influenza. Both pertussis and influenza in very young infants have significant morbidity (primarily hospitalization) and at times death. Studies have shown that an adolescent or adult contact is often the source of these two respiratory pathogens for infants and children. Because of this, it is postulated that one of the best means of protecting these infants is to vaccinate the household contacts, especially the birth mother. Accordingly, the Advisory Committee on Immunization Practices recommends that persons who have close contact with young infants receive influenza vaccine as well as combined tetanus toxoid, diphtheria toxoid and reduced dose acellular pertussis vaccine (Tdap). However, data reveal that only 13 percent of mothers of newborns report receiving influenza vaccine and limited data for uptake of Tdap in birth mothers ? are available. Strategies to improve vaccine delivery of Tdap and influenza to household contacts of newborns, especially birth mothers, are needed. The primary aim of this project is to develop and implement a hospital-based strategy of vaccinating birth mothers with Tdap year round and influenza vaccine during influenza season (October to March) using a standing order. In addition, this project seeks to define barriers and to develop and implement strategies to vaccinate household contacts of newborn infants with Tdap (year-round) and influenza during the influenza season. The proposal seeks to implement a standing order for vaccination of birth mothers during hospitalization at a community hospital,including documenting the processes, evaluating the barriers encountered and strategies with the most success, and comparing the overall vaccination uptake (effectiveness of these strategies) with a control community hospital. Methods developed, coupled with educational materials, will then form a tool-kit that will be shared with other hospitals nationally for implementation. This proposal also seeks to explore an expanding role of the hospital-based pharmacists in providing vaccines to household contacts. In addition, the proposal will consider the cost-benefit of a standing order related to the predicted prevention of morbidity and mortality in young infants due to pertussis and influenza. ? ? ?

Public Health Relevance

The results of this research project will allow the development of hospital-based vaccination of birth mothers with Tdap and influenza. Improving vaccination of birth mothers with these vaccines will help to protect vulnerable infants from significant morbidity and mortality due to pertussis and influenza. This will reduce the burden of disease in this population which will benefit public health.

Agency
National Institute of Health (NIH)
Institute
National Center for Immunication and Respiratory Diseases (NCIRD)
Type
Research Project--Cooperative Agreements (U01)
Project #
1U01IP000192-01
Application #
7584547
Study Section
Special Emphasis Panel (ZCD1-SMW (02))
Program Officer
Hopkins, Andrew S
Project Start
2008-09-01
Project End
2010-08-31
Budget Start
2008-09-01
Budget End
2009-08-31
Support Year
1
Fiscal Year
2008
Total Cost
$224,474
Indirect Cost
Name
La Biomed Research Institute/ Harbor UCLA Medical Center
Department
Type
DUNS #
069926962
City
Torrance
State
CA
Country
United States
Zip Code
90502
Yeh, Sylvia; Mink, ChrisAnna; Kim, Matthew et al. (2014) Effectiveness of hospital-based postpartum procedures on pertussis vaccination among postpartum women. Am J Obstet Gynecol 210:237.e1-6
Ding, Yao; Yeh, Sylvia H; Mink, Chris Anna M et al. (2013) Cost-benefit analysis of hospital based postpartum vaccination with combined tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap). Vaccine 31:2558-64
Ding, Yao; Zangwill, Kenneth M; Hay, Joel W et al. (2012) Cost-benefit analysis of in-hospital influenza vaccination of postpartum women. Obstet Gynecol 119:306-14